We identified multiple metabolites that are altered in orthotopic MYC-amplified medulloblastoma xenografts compared to normal brain and showed in a large clinical dataset that the mRNAs for key enzymes in these pathways are upregulated. The gene discussed is MYC; the disease is medulloblastoma.